Results 71 to 80 of about 222,830 (234)

Hypertrophic cardiomyopathy: genetics and clinical perspectives.

open access: yesCardiovascular Diagnosis and Therapy, 2019
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and defined by unexplained isolated progressive myocardial hypertrophy, systolic and diastolic ventricular dysfunction, arrhythmias, sudden cardiac death and histopathologic ...
C. Wolf
semanticscholar   +1 more source

Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.

open access: yesJAMA cardiology, 2019
Importance Racial differences are recognized in multiple cardiovascular parameters, including left ventricular hypertrophy and heart failure, which are 2 major manifestations of hypertrophic cardiomyopathy. The association of race with disease expression
L. Eberly   +16 more
semanticscholar   +1 more source

The genetics of hypertrophic cardiomyopathy

open access: yesGlobal Cardiology Science and Practice, 2018
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, caused by mutations in genes encoding cardiac sarcomere proteins. Other inheritable causes of the disease include mutations in genes coding for proteins important in calcium handling or that form part of the cytoskeleton. At present, the primary clinical role
Akhtar, M, Elliott, P
openaire   +5 more sources

Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice

open access: yesNature Network Boston, 2023
A. C. Chai   +12 more
semanticscholar   +1 more source

Genetics of hypertrophic cardiomyopathy: A review of current state

open access: yesClinical Genetics, 2018
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease. HCM is a highly complex and heterogeneous disease regarding not only the number of associated mutations but also the severity of phenotype, symptom burden, and the ...
M. Sabater-Molina   +3 more
semanticscholar   +1 more source

CARDIOMYOPATHY: The diagnosis of hypertrophic cardiomyopathy [PDF]

open access: yesHeart, 2001
Although the pathology of hypertrophic cardiomyopathy (HCM) was first described by French pathologists in the mid 19th century, it remained for the virtually simultaneous reports of Brock and Teare in England some 43 years ago to bring modern attention to this fascinating entity.1 2 Subsequent to these surgical1 and pathological2 observations, there ...
openaire   +3 more sources

Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis

open access: yesJournal of Nanobiotechnology
Background Cardiac fibrosis plays a critical role in the progression of various forms of heart disease, significantly increasing the risk of sudden cardiac death.
Xueli Zhao   +13 more
doaj   +1 more source

Automatic Segmentation and Disease Classification Using Cardiac Cine MR Images [PDF]

open access: yesarXiv, 2017
Segmentation of the heart in cardiac cine MR is clinically used to quantify cardiac function. We propose a fully automatic method for segmentation and disease classification using cardiac cine MR images. A convolutional neural network (CNN) was designed to simultaneously segment the left ventricle (LV), right ventricle (RV) and myocardium in end ...
arxiv  

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.

open access: yesJournal of the American College of Cardiology, 2022
B. Maron   +8 more
semanticscholar   +1 more source

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY

open access: yesРоссийский кардиологический журнал, 2014
The review is dedicated to the description of genetic alterations, pathogenetic mechanisms and pathophysiology of hypertrophic cardiomyopathy, based on the analysis of current up to date information.
N. T. Vatutin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy